These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 1665407)
1. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment. Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407 [TBL] [Abstract][Full Text] [Related]
2. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension. O'Connor DT; Mosley CA; Cervenka J; Bernstein KN J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882 [TBL] [Abstract][Full Text] [Related]
3. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients. Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608 [TBL] [Abstract][Full Text] [Related]
4. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade. Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939 [TBL] [Abstract][Full Text] [Related]
5. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes. Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521 [TBL] [Abstract][Full Text] [Related]
6. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study. Jenkins DA; Cowan P; Patrick AW; Clarke BF Nephrol Dial Transplant; 1993; 8(3):200-5. PubMed ID: 8385284 [TBL] [Abstract][Full Text] [Related]
7. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Vogt L; Kocks MJ; Laverman GD; Navis G Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515 [TBL] [Abstract][Full Text] [Related]
8. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
9. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients. Cooper ME J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709 [TBL] [Abstract][Full Text] [Related]
10. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension. Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383 [TBL] [Abstract][Full Text] [Related]
11. Blood pressure reduction as a preventive treatment of diabetic nephropathy. Ribstein J; Mimran A Clin Invest Med; 1991 Dec; 14(6):661-70. PubMed ID: 1794216 [TBL] [Abstract][Full Text] [Related]
12. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats. Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596 [TBL] [Abstract][Full Text] [Related]
13. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria. Poulsen PL J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749 [TBL] [Abstract][Full Text] [Related]
14. [Are all antihypertensive drugs renoprotective?]. Wolf S; Risler T Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950 [TBL] [Abstract][Full Text] [Related]
15. Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy. Pedersen MM; Hansen KW; Schmitz A; Sørensen K; Christensen CK; Mogensen CE Kidney Int; 1992 Apr; 41(4):883-90. PubMed ID: 1355149 [TBL] [Abstract][Full Text] [Related]
16. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study. Björck S Scand J Urol Nephrol Suppl; 1990; 126():1-51. PubMed ID: 2194280 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive treatment inhibiting the progression of diabetic nephropathy. Mogensen CE Acta Endocrinol Suppl (Copenh); 1980; 238():103-8. PubMed ID: 6933807 [TBL] [Abstract][Full Text] [Related]
18. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy. Abu-Romeh SH; Nawaz MK; Ali JH; Al-Suhaili AR; Abu-Jayyab AK Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602 [TBL] [Abstract][Full Text] [Related]